On 26 November 2018 Food and Drug Administration (FDA) Commissioner Scott Gottlieb and Center for Devices and Radiological Health (CDRH) Director Jeffrey Shuren issued a joint statement proposing to rebrand and modernize the 510(k) premarket review pathway with the goal of "efficiently advancing beneficial technology to patients, while solidifying FDA's gold standard for safety."
Please see full publication below for more information.